Summit Asset Management
AMGN icon

Summit Asset Management’s Amgen AMGN Stock Holding History

Summit Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$270K Buy
+641
New +$255K 0.03% 161

Other funds holding AMGN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Summit Asset Management's AMGN Position: Q3 2026 in Review

Summit Asset Management opened a new position in Amgen (AMGN) in Q3 2026: 641 shares worth $270K. The stake represents 0.03% of the portfolio and ranks #161 among its holdings.

2,318 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Summit Asset Management held 641 shares of Amgen worth $270K as of Q3 2026.
  • Amgen was a new Summit Asset Management position in Q3 2026.
  • Amgen made up 0.03% of Summit Asset Management's portfolio in Q3 2026, its #161 holding.
  • 2,318 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Summit Asset Management's 13F filing for Q3 2026, filed 5 Nov 2026.